Skip to main content

Patient Services Vie For Bigger Share Of AIDS Funds

WASHINGTON-In the early 1980s, the lonely voices seeking funds for AIDS research were barely audible amid the din from the biomedical community as a whole. Over the past eight years, however, with the public also demanding that science step up its battle against the devastating-disease, the United States government has poured $5.5 billion into the AIDS epidemic, including $2.1 billion in the current year ending September 30. So far, about 40% of that total, nearly $2.2 billion, has been spent on

Written byElizabeth Pennisi
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00

However, while the investment in basic research has added greatly to the store of knowledge about the AIDS virus, it has not yet led to an effective treatment: much less a cure. At the same time, more people are getting sick and living longer with the disease. And their plight threatens to control the hearts and. purse strings of society and drown out those who advocate the cause of science.

"AIDS is now a treatable disease," says Reed V. Tuckson, District of Columbia commissioner of health. "The implications of that are tremendous. Few health care systems are equipped to handle what's coming; nor is there much planning going on." Given the nation's limited resources, he adds, efforts to cope with the problem are "going to make Americans look like barbarians."

For scientists, the overwhelming need for care forebodes a potential squeeze on scarce resources. "We have a national consensus on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays